25.27
Antilichaamacties
Antilichamen, of immunoglobulinen, zijn cruciale spelers in het arsenaal van het immuunsysteem tegen binnendringende pathogenen. Ze worden geproduceer…
Antibodies recognize and bind antigens to form antigen-antibody complexes for pathogen elimination.
After binding to an antigen, the antibody neutralizes the pathogen by obstructing the antigen's interaction with receptors on the host cell membrane, curbing the spread of infection.
As each antibody molecule has two binding sites for the same antigen, it can cross-link antigens on different pathogenic molecules.
As a result, antibodies can link different antigenic molecules into large, insoluble immune complexes.
When soluble antigens, such as toxins, form large complexes, they precipitate out of the solution.
In contrast, antigens on bacterial cells or viral particles that are cross-linked by antibodies cause clumping or agglutination.
In both cases, the phagocytes easily capture and engulf these large immune complexes.
When multiple antibodies bind closely on a cell, their stem regions align to allow the binding of complement proteins, triggering pathogen lysis.
Additionally, the coat of antibodies and complement proteins opsonizes, or tags, pathogens for phagocyte recognition.
These opsonized pathogens are easily gripped by phagocytes for effective elimination.
View the full transcript and gain access to JoVE Core videos
Q1: How do antibodies neutralize pathogens?
Antibodies bind to antigens on pathogens and block their interaction with host cell receptors, preventing infection. This neutralization mechanism stops pathogens from entering cells and spreading infection. Antibodies can also bind toxins like tetanus toxin, preventing their harmful effects on tissues.
Q2: What is antigen-antibody cross-linking and why does it matter?
Each antibody has two binding sites, allowing it to link different antigenic molecules together into large immune complexes. Soluble antigens form precipitates that settle out of solution, while antigens on bacterial cells or viruses clump through agglutination. These large complexes are easily captured and eliminated by phagocytes.
Q3: How do antibodies activate the complement system?
When multiple antibodies bind closely on a pathogen's surface, their stem regions align to allow complement proteins to attach. This triggers pathogen lysis and destruction. Complement activation amplifies the immune response and recruits additional immune cells to the infection site for enhanced defense.
Q4: What is opsonization and how do antibodies facilitate it?
Opsonization is the process where antibodies and complement proteins tag pathogens for recognition by immune cells. These opsonized pathogens are easily gripped and engulfed by phagocytes for effective elimination. This marking system enhances the efficiency of pathogen removal from the body.
Q5: How do antibodies contribute to inflammation?
Antibodies trigger inflammation by binding to antigens and activating the complement system, which releases inflammatory mediators. This inflammatory response recruits more immune cells to the infection site, amplifying the body's defense against pathogens. The coordinated response enhances pathogen elimination and tissue protection.
Q6: What are the main functions of antibodies in immune defense?
Antibodies recognize and bind specific antigens to neutralize pathogens, prevent infection, and form immune complexes for phagocyte removal. They activate complement proteins, opsonize pathogens for recognition, and trigger inflammation. These diverse functions make antibodies indispensable in the body's defense against bacterial and viral infections.
Q7: How do antibodies enhance phagocytosis?
Antibodies facilitate phagocytosis by acting as opsonins that mark pathogens for immune cell recognition. When antibodies coat pathogen surfaces alongside complement proteins, phagocytes recognize and engulf these tagged pathogens more efficiently. This enhanced recognition and elimination process is critical for clearing infections from the body.